Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today announced it has received an NBS 5+ system order from Seattle Children’s in the United States. The Nexstim NBS 5+ system, released in 2021, gives customers access to the software of both Nexstim’s NBS (Navigated Brain Stimulation) and NBT® (Navigated Brain Therapy) systems. This means that the system can be
Press release, Helsinki, 30 May 2022 at 11 AM (EEST) Nexstim to Present at Redeye Growth Day 2022 Nexstim Plc’s (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") CEO Mikko Karvinen will be taking part in Redeye Growth Day 2022 in Stockholm on Thursday 2 June 2022. A pre-recorded presentation is already available at Nexstim’s event space. An extensive Q&A session will be live broadcasted at the Redeye Growth Day 2022 event space on 2 June at 11:05 CEST (12:05 EEST). Further information is available
Press release, Helsinki, 24 May 2022 at 12:30 PM (EEST) Nexstim Receives an Order for Two NBS Systems from a Finnish University Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received an order for two NBS 5 systems from a university hospital in Finland. The customer is an experienced user of the Nexstim NBS 4 system, now acquiring the two new systems to replace the old system and to increase capacity. Nexstim’s NBS (Navigated Brain Stimulation) system is used, for examp